GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lumosa Therapeutics Co 6535.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

71.50

+1.85%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 35.8m

FY2016FY2025

Net income

−TWD 340.5m

FY2016FY2025

Free cash flow

−TWD 361.2m

FY2016FY2025

Shareholders' equity

TWD 1.51bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 35.8mTWD 39.2mTWD 56.9mTWD 26.6mTWD 17.4mTWD 21.7mTWD 172.0mTWD 60.6mTWD 35.3mTWD 12.5m
Research and developmentTWD 304.4mTWD 322.9mTWD 369.3mTWD 280.5mTWD 406.0mTWD 317.0mTWD 212.2mTWD 126.7mTWD 136.9mTWD 243.9m
Operating income−TWD 333.5m−TWD 356.9m−TWD 249.9m−TWD 504.3mTWD 96.2m−TWD 322.4m−TWD 150.0m−TWD 138.1m−TWD 195.5m−TWD 267.5m
Net income−TWD 340.5m−TWD 424.8m−TWD 238.0m−TWD 494.7mTWD 95.9m−TWD 322.6m−TWD 240.9m−TWD 50.4m−TWD 212.8m−TWD 229.6m
Diluted earnings per share-2.02-2.61-1.47-3.050.64-2.67-2.05-0.51-2.23-2.63

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.65bnTWD 2.13bnTWD 1.66bnTWD 1.89bnTWD 2.35bnTWD 1.78bnTWD 1.32bnTWD 1.39bnTWD 808.8mTWD 918.3m
Cash and short-term investments——TWD 844.3mTWD 1.18bnTWD 1.45bnTWD 1.27bnTWD 625.0mTWD 907.3mTWD 763.1mTWD 818.2m
Total liabilitiesTWD 131.0mTWD 205.5mTWD 227.7mTWD 215.7mTWD 230.1mTWD 201.6mTWD 278.4mTWD 121.4mTWD 117.1mTWD 45.9m
Debt—TWD 8.5mTWD 12.6mTWD 4.7mTWD 11.5mTWD 17.0mTWD 11.7m———
Shareholders' equityTWD 1.51bnTWD 1.91bnTWD 1.40bnTWD 1.63bnTWD 2.12bnTWD 1.58bnTWD 1.05bnTWD 1.27bnTWD 691.7mTWD 872.4m
Shares outstanding168m162m162m162m151m121m118m99m96m87m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 360.5m−TWD 296.3m−TWD 328.2m−TWD 300.5m−TWD 452.6m−TWD 129.1m−TWD 379.5m−TWD 81.9m−TWD 68.4m−TWD 143.5m
Capital spending−TWD 668,000−TWD 450,000−TWD 15.0m−TWD 2.3m−TWD 576,000−TWD 680,000—−TWD 5.2m−TWD 2.1m−TWD 3.8m
Free cash flow−TWD 361.2m−TWD 296.8m−TWD 343.2m−TWD 302.7m−TWD 453.2m−TWD 129.8m−TWD 379.5m−TWD 87.1m−TWD 70.5m−TWD 147.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 5.1mTWD 4.5mTWD 13.1mTWD 11.7mTWD 2.2mTWD 8.9mTWD 19.8mTWD 6.4m
Operating income−TWD 121.0m−TWD 66.5m−TWD 43.4m−TWD 72.4m−TWD 111.2m−TWD 106.4m−TWD 115.3m−TWD 87.8m
Net income−TWD 161.9m−TWD 119.7m−TWD 55.6m−TWD 32.8m−TWD 147.9m−TWD 104.2m−TWD 148.5m−TWD 228.0m
Diluted earnings per share-0.97-0.71-0.33-0.19-0.88-0.62-0.91-1.40
Cash from operations−TWD 116.0m−TWD 51.0m−TWD 42.0m−TWD 50.0m−TWD 186.0m−TWD 81.0m−TWD 100.0m−TWD 51.0m
Total assetsTWD 1.37bnTWD 1.53bnTWD 1.65bnTWD 1.73bnTWD 1.75bnTWD 2.05bnTWD 2.13bnTWD 1.38bn
Shareholders' equityTWD 1.24bnTWD 1.39bnTWD 1.51bnTWD 1.59bnTWD 1.62bnTWD 1.81bnTWD 1.91bnTWD 1.15bn

Financial ratios

Data as of 22 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-930.8%-911.6%-439.0%-1892.9%554.1%-1489.1%—
Net margin-950.4%-1084.9%-418.2%-1856.7%552.6%-1489.8%—
Return on equity-22.6%-22.2%-17.0%-30.4%4.5%-20.4%—
Return on assets-20.6%-19.9%-14.4%-26.2%4.1%-18.1%—
Free cash flow yield—-2.3%-2.5%-2.4%———
Revenue growth-8.5%-31.2%113.6%53.5%-19.8%-87.4%—
Earnings growth-19.8%78.4%-51.9%-615.6%-129.7%33.9%—
Current ratio7.37x7.64x4.75x6.44x7.23x7.07x—
Debt to equity——0.00x0.00x0.00x0.00x0.01x
Equity ratio91.5%89.6%84.6%86.4%90.2%88.7%—
Interest coverage-1659.22x-1908.79x-5316.74x-3384.54x370.02x-2135.19x—
R&D as a share of sales849.5%824.6%648.9%1052.7%2338.7%1464.3%—
Buybacks as a share of market value—-0.0%-0.0%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.4%10.6%14.2%
Operating income-12.9%0.7%2.8%
Net income-11.7%1.1%3.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-920.8%-911.2%-845.8%-549.0%
Net margin-1020.6%-944.9%-873.0%-552.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-96.2-95.6-46.6-12.963.3-13.2-16.7-59.8-13.2-16.8
Price to sales——194.9240.2349.9195.923.449.779.6309.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.